The regioselective synthesis of estrogens and their derivatives continues to be of interest. Most reported syntheses require multistep protocols associated with poor overall yield and lack of regioselectivity. New preparative protocols are still desired. Herein, 11 2-alkylated 17β-estradiol analogs were synthesized in a highly regioselective manner. The products were obtained using a convenient, one pot and high-yielding protocol. The anti-proliferative activity of the compounds was tested in human T-cell leukemia (CEM), human cervix carcinoma (HeLa) and human dermal microvascular endothelial (HMEC-1) cells.
Introduction
The estrogen 2-methoxyestradiol (2-ME, 1) was long believed to be an inactive endogenous metabolite of 17β-estradiol (2) . However, in 1994, D'Amato, Folkman and co-workers showed that 2-ME (1) inhibits tubulin polymerization by interfering with the colchicine binding-site [1, 2] . Later studies revealed that the steroid 1 also blocks endothelial cell migration and proliferation in vitro [3] . Moreover, when administered to tumor-bearing mice, 2-ME (1) inhibited the vascularization and growth of solid tumors [2, 4] . In addition, it was reported that 2-ME (1) downregulates hypoxia-inducible factor-1α (HIF-1α) resulting in potent cytotoxic effects in prostate and breast cancer cells [5] . These observations were confirmed by in vivo studies that also showed that intrinsic and extrinsic apoptotic pathways were mediated by 2-ME (1) and its metabolites [6, 7] . 2-Methoxyestradiol (1) has entered several clinical trials that revealed no severe toxic effects, even when doses as high as 3 g per day were administrated [8] [9] [10] [11] .
The aforementioned pharmacological activities have inspired several studies where 2-ME (1) has been used as a lead compound for the development of new anti-cancer agents [12] . Some examples of such analogs are depicted in Fig. 1 .
We have previously used the steroid 1 as a lead compound for the synthesis of potential new anti-cancer agents [13] [14] [15] . The alkyl-substituent at C-2 seems interesting to alter in further efforts. The classic Friedel-Crafts reaction is the method of choice for the introduction of secondary or tertiary alkyl groups in aromatic compounds, including phenols, such as 17β-estradiol [16, 17] . Although this method has been improved over the years the alkylation of primary alkyl groups is still a huge challenge [17] . Most often this approach yields a mixture of rearrangement and polyalkylation products. Moreover, often harsh acidic or basic reaction conditions are required rendering the usefulness of the direct mono-alkylation of aromatics limited [18, 19] . The introduction of primary alkyl groups is therefore instead performed using multistep protocols [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] . These aforementioned drawbacks, as well as the challenge of achieving high regioselectivity, also apply to the synthesis of mono-alkylated estrogenic steroids, such as 2-ethylestradiol (4a). Towards tackling the challenge of developing a regioselective and easy synthesis of 2-ethylestradiol, we reported the application of a highly regioselective ortho-formylation protocol [31] [32] [33] of estradiols and estrogens [34] . These studies also resulted in a multi-step synthesis of 2-ethylestradiol (4a) [15] that required chromatographic separation of the 2-substituted salicylaldehyde 8 from its 4-substituted regioisomer 9 (Scheme 1).
Since 2-substituted alkylated analogs of 2-methoxyestradiol (1), such as 5 and 6 ( Fig. 1 ) displayed interesting inhibition of polymerization of tubulin along with cytotoxic and anti-angiogenic effects [13] [14] [15] , we became interested in conducting additional structural-activity relationship studies using 1 as the lead compound. Recently
Parnes and Pappo reported a convenient and highly regioselective multi-component reductive alkylation reaction of aromatic compounds [35] . The formation of the alkylation product was mediated by an in situ formed thionium ion from an aldehyde and ethanethiol under mild catalytic acidic conditions. The resulting 1-(alkylthio)alkylarenes were reduced by triethylsilane to the mono-alkylated product in good to excellent yields. In their successful method development efforts, Parnes and Pappo reported two examples using 2 in the aforementioned protocol, affording the 2-isobutyl and 2-benzyl substituted products in 67% and 85% isolated yield, respectively. These results spurred our interest in the synthesis and cytotoxic evaluations of analogs of 2-methoxyestradiol (1), applying this Pummerer-type reaction. These studies are 
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Steroids 124 (2017) [54] [55] [56] [57] [58] [59] communicated herein.
Experimental

General
Under an inert atmosphere, 17β-estradiol (1) (0.27 g, 1.0 mmol), aldehyde (3.0 mmol), copper(II) trifluoromethanesulfonate (9.0 mg, 2.5 mol%), and 2,2,2-trifluoroethanol (3.0 mL) were combined in a round-bottom flask. Ethanethiol (0.44 mL, 6.0 mmol) was added and the reaction mixture was stirred 16 h at 50°C. Triethylsilane (0.48 mL, 3.0 mmol) was then added and the mixture was allowed to stir for an additional 4 h at 50°C. Analysis by TLC (ethyl acetate:heptane, 30:70) indicated a complete reaction. Removal of volatiles was performed in vacuo where the exhaust was passed through a solution over basic potassium permanganate solution to quench excess ethanethiol. The residue was purified by flash chromatography (ethyl acetate:heptane, 30:70) to afford the products (4a-4k). 
(8R,9S,13S,14S,17S)-2-Ethyl
Cancer cell growth inhibition
Human cervical carcinoma (HeLa) cells were seeded in 96-well plates at 15,000 cells/well in the presence of 5-fold dilutions of the compounds. After 3 days of incubation, the cells were trypsinized and counted by means of a Coulter counter (Analis, Belgium). Human dermal microvascular endothelial (HMEC-1) cells were seeded on gelatin-coated 48-well plates at 20,000 cells/well. After overnight incubation, 5-fold dilutions of the compounds were added. Three days later, the cells were trypsinized and counted. Human T-cell leukemia (CEM) cells were seeded in 96-well plates at 60,000 cells/well in the presence of the compounds, allowed to proliferate for 4 days and then counted. The 50% inhibitory concentration (IC 50 ) was defined as the compound concentration required to reduce cell proliferation by 50% [38] .
Results
Chemistry
The synthesis of the analogs started with the preparation of the steroid 4a as outlined in Scheme 2. Commercially available 17β-estradiol (2) was added together with acetaldehyde, copper(II) trifluoromethanesulfonate and ethanethiol and stirred in 2,2,2-trifluoroethanol at 50°C overnight. Then triethylsilane was added, and the mixture was stirred at 50°C for additional four hours. The desired 2-ethyl substituted estrogen 4a was obtained in excellent 80% isolated yield after chromatographic purification. Gratifyingly, only one regioisomer of 4a was detected by HPLC analysis of the crude reaction mixture and by comparison with NMR data from literature [34, 35] . In the 1 H NMR spectrum of 4a two singlet signals were observed at 7.06 ppm and 6.50 ppm as expected for a 2-substituted estradiol [34, 35] . The singlet at 7.06 ppm in the 1 H NMR spectrum is observed for H1 (Fig. 1) , as determined by interpretation of the cross peaks detected for this singlet in the HSQC and HMBC NMR spectra (see Supporting information). For a 4-substituted estradiol one would expect the presence of two doublets with equal ortho-coupling constant integrating for one hydrogen each in the aromatic region, as reported earlier [34, 39] . The 13 C NMR-and the 2D NMR-spectra (COSY45, HSQC and HMBC) also supported the formation of 2-ethylestradiol (see Supporting information). In particular the HMBC-spectrum provided additional support for the formation of 2-ethylestradiol (4a) as the singlet at 7.06 ppm in the 1 H NMR spectrum showed correlation with signals at 22.9 ppm and 14.2 ppm in the 13 C NMR spectrum arising from the CH 2 -and the CH 3 -group in the ethyl-substituent, respectively. For the other n-alkylated aldehydes subjected to the same conditions, good to high yields in the range of 64-73% were observed for the products 4b-4d, Scheme 2. Sterically more demanding aldehydes were also tested, that returned the desired 2-alkylated estrogen in 69% and 34% isolated yields of 4e and 4f, respectively. For 2-neopentylestradiol (4f) the yield was poor, most likely due to the steric hindrance of pivaldehyde. Disappointingly, 3-methylbut-2-enal did not return any of the 2-substituted product as only the starting material 2 was recovered.
The introduction of a prenyl-group in either the 2-or the 4-position of 2 would be of interest towards a biomimetic synthesis of naturally occurring terpenoid-derived estradiols [40] . When benzaldehydes were used, high (70%) to excellent yields (89%) were observed, as observed for products 4g-4j. The electron-releasing para-methoxy benzaldehyde resulted in a 60% isolated yield of 4k. Of note, neither 2-thiophene carboxaldehyde nor 2-furane carboxaldehyde reacted in this reaction. In both cases 17β-estradiol (2) was recovered unreacted. The spectral data of all known as well as new products were in accord with their assigned structures. Our attempts when using estrone or its 17-ethylene acetal with acetaldehyde gave complex reaction mixtures in both cases.
Biological evaluations
The 2-alkylated analogs were submitted to human T-cell leukemia (CEM), human cervix carcinoma (HeLa) and human dermal microvascular endothelial cells (HMEC-1) for the evaluation of their antiproliferative effects. The data are expressed as IC 50 (50% inhibitory concentration), which is defined as the compound concentration that reduces cell proliferation by 50%, and are shown in Table 1 . The reference compound 2-ME (1) inhibited the growth of all cell lines tested in the low micromolar range (IC 50 between 0.4 and 1.6 µM). The most potent compound was the 2-ethyl analog 4a with IC 50 values of 5.6 ± 0.8 and 9.5 ± 0.9 µM towards the CEM and HeLa cell lines, respectively. None of the compounds inhibited the growth of the endothelial cell line, which may point to a tumor-selective mechanism of action. However, since they were less potent than 2-ME (1), no further biological studies were conducted.
Conclusions
Structure-activity relationship (SAR) studies have shown that the endogenously formed metabolite of 17β-estradiol (2), namely 2-methoxyestradiol (1), is amendable for changes in the 2-position of the Aring [41] . Several alkyl substituents in this position were easily introduced in 2 using a recently reported one-pot protocol [35] . The yields of the alkylated products were high to excellent, except for one example. This one-pot protocol is easy to conduct compared to the multi-step protocols previously reported [15, 36, 37, 42] . One-pot protocols offer many advantages, such as avoiding isolation, handling and chromatography of intermediates leading to time-cost benefits. The 17-acetate of 17β-estradiol (2), estrone and its ethylene-acetal did not react in this protocol. The 2-ethyl analog of 17β-estradiol (2), which displayed selective and decent cytotoxic effects, should be useful as a lead compound for further structural-activity studies where alterations are to be performed at the C17-position. Such analogs are of interest towards the development of novel analogs of 2-ME (1) [43] . Table 1 Anti-proliferative activity of 2-alkyl analogs 4a-4k and 2-ME (1). 
